Healthcare Triangle Files Pro Forma Financials for Teyamé & Datono Acquisitions, Revealing Substantial Revenue Boost
HCTI is trading near its 52-week low of $2.28 (9.6% above the low) on light trading volume (0.2× avg).
Summary
Healthcare Triangle filed an amended 8-K to provide audited financial statements for its acquired entities, Teyamé 360 S.L. and Datono Mediación S.L., along with pro forma combined financial information, revealing a significant increase in the company's revenue base.
Key Events · M&A and Partnerships · HCTI
-
Acquisition Financials Disclosed
The filing includes audited financial statements for Teyamé 360 S.L. and Datono Mediación S.L., acquired by Healthcare Triangle's subsidiary, Teyame AI Holdings Inc.
-
Pro Forma Revenue Significantly Increased
Unaudited pro forma combined financial information shows a net revenue of $44.815 million for the combined entity in 2025, a substantial increase from Healthcare Triangle's standalone revenue.
-
Acquired Entities Were Profitable
Teyamé 360 S.L. reported a net profit of $1.103 million and Datono Mediación S.L. reported a net profit of $0.466 million in 2025, potentially improving Healthcare Triangle's overall profitability.
-
Amendment to Prior Acquisition Disclosure
This 8-K/A amends the original 8-K filed on January 28, 2026, to provide the required financial statements and pro forma information for the acquisition.
Analysis · HCTI · Technology
This 8-K/A filing provides crucial financial details for Healthcare Triangle's previously announced acquisition of Teyamé 360 S.L. and Datono Mediación S.L. The inclusion of audited financial statements for the acquired businesses and unaudited pro forma combined financials is highly significant. The pro forma statements indicate a substantial increase in Healthcare Triangle's revenue base, with the combined entity showing over $44 million in net revenue for 2025, compared to Healthcare Triangle's standalone revenue of approximately $13.89 million. Furthermore, the acquired entities were profitable, which could materially improve Healthcare Triangle's overall financial performance, as the company reported a net loss. This filing is essential for investors to fully assess the financial impact and strategic value of the acquisition.
At the time of this filing, HCTI was trading at $2.50 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $2.28 to $7,469.93. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.